# A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections

> **NCT01110408** · PHASE3 · TERMINATED · sponsor: **Janssen Research & Development, LLC** · enrollment: 41 (actual)

## Conditions studied

- Complicated Urinary Tract Infections or Pyelonephritis

## Interventions

- **DRUG:** Doripenem
- **DRUG:** Doripenem placebo
- **DRUG:** Cefepime
- **DRUG:** Cefepime placebo
- **DRUG:** Amoxicillin/clavulanate potassium

## Key facts

- **NCT ID:** NCT01110408
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 41 (ACTUAL)
- **Why stopped:** Trial terminated early per business decision
- **Last updated:** 2014-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110408, "A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01110408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*